Liracen 1,25 mg, 2,5 mg, 5 mg and 10 mg Capsule
PDF Leaflet Revision Date: 06 December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Mild to moderate hypertension and heart failure post-myocardial infarction.
Dosage (summary)
Initial: 2.5 mg once daily, max 10 mg.
Onset of Action / Duration
Onset: 1-2 hours, Duration: 24 hours
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated; can cause fetal harm.
Key Drug Interactions
- Potassium sparing diuretics
- Lithium
- NSAIDs
Contraindications
- Angioedema history
- Severe renal impairment
- Pregnancy
Common side effects
- Dizziness
- Dry cough
- Fatigue
Counselling Points
- Monitor blood pressure
- Avoid potassium supplements
- Report any swelling or difficulty breathing
Serious warnings
- Risk of hypotension
- Angioedema
- Hyperkalaemia
Important Disclaimer
The Liracen 1,25 mg, 2,5 mg, 5 mg and 10 mg Capsule professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
